⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3761033 | 0.89 | — | — | |
| SCHEMBL14477544 | 0.80 | — | — | |
| SCHEMBL12744110 | 0.80 | — | — | |
| SCHEMBL16674734 | 0.78 | — | — | |
| SCHEMBL18911589 | 0.77 | — | — | |
| 1,2-Dibromoethane SCHEMBL1448860 | 0.76 | — | — | |
| SCHEMBL13916473 | 0.75 | — | — | |
| SCHEMBL12788033 | 0.74 | — | — | |
| SCHEMBL17812881 | 0.73 | — | — | |
| 1-Bromobutane SCHEMBL14169608 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130904-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2026-05-14 | — | — | US | disclosed |
| US-20250025467-A1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2025-01-23 | — | — | US | disclosed |
| US-20230355629-A1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2023-11-09 | — | — | US | disclosed |
| US-20230099694-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-03-30 | — | — | US | disclosed |
| US-20210330674-A1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | CONCERT PHARMACEUTICALS INC (US) | 2021-10-28 | — | — | US | disclosed |
| EP-3882249-A1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | CoNCERT Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |
| CN-110229159-B | Deuterated derivative of ruxotinib | 康塞特医药品有限公司 | 2021-08-24 | — | — | CN | disclosed |
| US-20210052575-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-02-25 | — | — | US | disclosed |
| EP-3450434-B1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | CONCERT PHARMACEUTICALS INC (US) | 2021-02-24 | — | — | EP | disclosed |
| US-20200061056-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-02-27 | — | — | US | disclosed |
| EP-2861600-A1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | Concert Pharmaceuticals Inc. (US) | 2015-04-22 | — | — | EP | disclosed |
| US-20150045356-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-02-12 | — | — | US | disclosed |
| WO-2013188783-A1 | DEUTERATED DERIVATIVES OF RUXOLITINIB | CONCERT PHARMACEUTICALS, INC. (US) | 2013-12-19 | — | — | WO | disclosed |
| WO-2013035892-A1 | PIPERAZINE- SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-14 | — | — | WO | disclosed |
| US-20110196012-A1 | DEUTERATED MACROCYCLIC INHIBITORS OF VIRAL NS3 PROTEASE | CONCERT PHARMACEUTICALS, INC. (US) | 2011-08-11 | — | — | US | disclosed |
| US-20110054020-A1 | NAPTHYLENE INHIBITORS OF CYCLOOXYGENASE | AUSPEX PHARMACEUTICALS, INC. (US) | 2011-03-03 | — | — | US | disclosed |
| US-20100305173-A1 | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100069399-A1 | ARYLPIPERAZINE MODULATORS OF D2 RECEPTORS, 5-HT1A RECEPTORS, AND/OR 5-HT2A RECEPTORS | AUSPEX PHARMACEUTICAL, INC. (US) | 2010-03-18 | — | — | US | disclosed |
| US-20100069399-A1 | ARYLPIPERAZINE MODULATORS OF D2 RECEPTORS, 5-HT1A RECEPTORS, AND/OR 5-HT2A RECEPTORS | AUSPEX PHARMACEUTICAL, INC. (US) | 2010-03-18 | — | — | US | disclosed |
| US-20080299216-A1 | DEUTERIUM-ENRICHED ARIPIPRAZOLE | PROTIA, LLC (US) | 2008-12-04 | — | — | US | disclosed |